近日， 商汤医疗 正式引入 河南汇融人工智能产业投资基金近亿元 战略投资 ， 凯乘资本 继续担任财务顾 问。作为河南省首支聚焦人工智能产业的主题基金，此次战略注资明确指向区域医疗体系的数智化升级与协同 建设，标志着商汤医疗"AI+医疗"战略在中原地区进入实质性落地阶段。 # 市场背景：AI 医 疗从" 工具试点"走向"体系级应用" 从行业整体看，AI 医疗正处在从技术验证向价值验证过渡的关键阶段。公开数据显示， 2023年我国 AI 医疗 行业市场规模约107亿元，同比增长超过50% ，在 "健康中国2030""医疗信息化十四五" 等政策推动下，AI 在诊前、诊中、诊后及科研管理等环节的应用持续扩展。 与早期聚焦影像识别或单一算法不同，当前医疗机构对 AI 的需求正在发生变化： 不再仅关注某一项诊断能力，而是更强调跨科室、跨流程、可持续演进的系统级工具。这也使得具备医疗大模 型能力、能够支撑多场景协同的 AI 医疗平台，开始在区域与大型医疗体系中获得更高关注度。 # 企业定位：以医疗大模型为中枢的"智慧医院"赋能者 在产品层面，商汤医疗已围绕 SenseCare ® 体系，形成多条可落地的应用模块： 在临床诊 ...

为实现 " 大脑 " 与多模态模型的高效协同，商汤医疗打造 " 双中台 " ： 大医 ®Bots 智能体开发平台支 持零代码孵化应用，已推出 " 大医智健 "" 大医智研 "" 大医医助 " 三款标准化产品；多模态基础模型应 用生产平台则实现医学图像 AI 应用的全生命周期零代码开发。在此基础上，公司构建了包含智慧诊疗、 智慧就医、智慧科研、智慧医疗云的四大平台矩阵，形成 " 数据 - 模型 - 场景 - 产业 " 的完整闭环。 商业落地方面，商汤医疗已取得多项突破： 临床端上线 40 余款 AI 模块，覆盖肺、心脏、肝脏等十余个 临床方向，其智慧病理系统可提升科室效率 30%-50% ，肿瘤检出敏感性接近 100% ；与北京清华长庚 医院合作推出肝脏智能决策多模态智能体，辅助完成超 400 例复杂肝切除手术；联合罗氏制药搭建的科 研平台，已覆盖全国 90 个城市 700 家三甲医院，助力 600 余项科研项目落地。此外，公司还与上海申 康医院发展中心共建医疗大数据训练设施，并为美的旗下和祐医院部署智慧诊疗平台，产品同步入驻联想 SSG 全渠道。 海外布局同样提速 ，商汤医疗已斩获新加坡首张 AI 胸部 CT ...

Core Insights - SenseTime has spun off an AI medical company that has quickly become a quasi-unicorn within six months [1] - The company aims to design and empower "future hospitals" driven by medical large models, focusing on comprehensive perception and deep understanding of medical scenarios [2][4] - SenseTime Medical has raised a total of 1 billion yuan in funding within a short period, with significant investments from various strategic partners [3] Business Strategy and Development - SenseTime Medical is a core extension of the group's "1+X" strategic ecosystem, with the group providing robust technical support [4] - The company has initiated its Series A financing round, aiming to further expand its capital base [3] - The team consists of around 100 members, with over 70% in research and development, featuring graduates from top global universities [20] Technology and Product Development - The AI system follows a "general-special integration" approach, utilizing a central "brain" to manage various medical image models and knowledge bases [6] - The self-developed medical large language model "Daiyi®" has outperformed other models in professional tests, showcasing its capabilities across multiple dimensions [8] - The company has developed a dual-platform system to enhance clinical thinking capabilities and facilitate collaboration among various AI applications [10][11] Clinical Applications and Impact - SenseTime Medical has launched over 40 AI modules targeting various clinical areas, significantly improving efficiency and diagnostic accuracy [14][15] - The "SenseCare®" solutions have demonstrated substantial improvements in clinical workflows, such as a 30%-50% increase in efficiency for pathology departments [15] - The company has partnered with leading hospitals and institutions to implement AI solutions, achieving notable results in surgical planning and research support [26][28][31] Market Expansion and Future Outlook - SenseTime Medical is actively expanding its market presence, having obtained the first AI+medical device registration in Singapore and initiating operations in Indonesia [33] - The company is focused on building a "world model" that simulates complex medical environments, moving beyond simple Q&A interactions [35][36] - Future strategies include deepening the "1+X" approach, with a focus on generative AI and visual AI as core business drivers [37][38]